Overview

Investigate the Effect of AZD1305 on Patients With Left Ventricular Dysfunction

Status:
Completed
Trial end date:
2009-07-01
Target enrollment:
Participant gender:
Summary
To explore if AZD1305 compromises left ventricular performance in patients with left ventricular dysfunction
Phase:
Phase 2
Details
Lead Sponsor:
AstraZeneca